Name | [Hydroxy(2-naphthyl)methyl]phosphonic acid |
---|---|
Synonyms | 2-naphthylhydroxymethylphosphonate |
Description | HNMPA is a membrane impermeable insulin receptor tyrosine kinase inhibitor. HNMPA inhibits serine and tyrosine autophosphorylation by the human insulin receptor. HNMPA has no effect on protein kinase C or cyclic AMP-dependent protein kinase activities[1][2] |
---|---|
Related Catalog | |
In Vitro | HNMPA inhibits the phosphorylation of a synthetic peptide substrate composed of insulin receptor residues 1290-1319 on serines-1305/1306 by partially purified insulin receptors[1]. HNMPA blocks GABA-dependent insulin inhibition, and reduces neuronal firing after GABA application[2]. |
References |
Density | 1.514g/cm3 |
---|---|
Boiling Point | 527.2ºC at 760mmHg |
Molecular Formula | C11H11O4P |
Molecular Weight | 238.17600 |
Flash Point | 272.6ºC |
Exact Mass | 238.03900 |
PSA | 87.57000 |
LogP | 2.00840 |
Hazard Codes | Xi |
---|
~82% 132541-52-7 |
Literature: Burke Jr.; Li; Bolen; Marquez Journal of Medicinal Chemistry, 1991 , vol. 34, # 5 p. 1577 - 1581 |
~% 132541-52-7 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 12, # 9 p. 1295 - 1298 |
~% 132541-52-7 |
Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 7, # 17 p. 2169 - 2172 |